Some aspects of laboratory diagnosis of viral hepatitis В and С
- Authors: Iliyina EN1, Govorun VМ2, Ivanikov IО3
-
Affiliations:
- НИИ физико-химической медицины Минздрава РФ
- НПФ "Литех"
- Медицинский центр Управления делами Президента РФ
- Issue: Vol 78, No 4 (2003)
- Pages: 84-86
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/29403
- ID: 29403
Cite item
Full Text
Abstract
Keywords
About the authors
E N Iliyina
НИИ физико-химической медицины Минздрава РФНИИ физико-химической медицины Минздрава РФ
V М Govorun
НПФ "Литех"НПФ "Литех"
I О Ivanikov
Медицинский центр Управления делами Президента РФМосква; Медицинский центр Управления делами Президента РФ
References
- Mullis К., Faloona F., Scharf S. et al. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. 1986. Biotechnology 1992; 24: 17-27.
- Barany F. Genetic disease detection and DNA amplification using cloned thermostable ligase. Proc Nat. Acad. Sci. USA 1991; 88: 189-193.
- Walker R. F. et al. A chemilnminescent DNA probe test based upon strand displacement amlification (SDA). In: Wiedbrauk D. L., ed. Molecular methods of virus detection. New York: Academic Press; 1995. Chapt. 15.
- Compton J. Nucleic acid sequence-based amplification. Nature 1991; 350: 83-85.
- Craig S. Hill. Gen-probe transcription-mediated amplification: system principles. Gen-Probe Incorporated, San Diego 1996.
- Urdea M. S. Synthesis and characterization of branched DNA for the direct and qualitative detection of CMV, HBV, HCV and HIV. Clin. Chem. 1993; 39: 725-726.
- Bathelier C., Mercier G., Lucotte G. A simplified semiquantitative determination of hepatitis С virus genome molecules by the end-poit dilution method. Mol. Cell Probes 1996; 10: 477-480.
- Lunel F., Cresta P., Vitour D. et al. Comparative evolution of hepatitis С virus RNA quantitation by branched DNA, NASBA and monitor assay. Hepatology 1999; 29: 528-535.
- Le Guen В., Squadrito G., Nalpas B. et al. Hepatitis С vims genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C. Ibid. 1997; 25: 1250-1253.
- Davis G. L., Lau J. Y. Factors predictive of a beneficial response to therapy of hepatitis C. Ibid. 26: 122S-127S.
- Рыжова Ю.Л., Фомин Е. А., Калинина О. В., Мукомолов С. Л. Индикация HBV ДНК в прогнозировании угрозы хронизации при остром гепатите В. Рос. журн. гастроэнтерол., гепатол., колопроктол. 1995; 5: 206-207.
- Stuyver L., Rossau R., Wyseur A. et al. Typing of hepatitis С virus isolates and characterization of new subtype using a line probe assay. J. Gen. Virol. 1993; 74: 1093-1102.
- Davidson F., Simmonds P.. Ferguson J. С. et al. Survey of major genotypes and subtypes of hepatitis С virus using RFLP of sequences amplified from the 5' non-coding region. Ibid. 1995; 76: 1197-1204.
- Lareu R. R., Swanson R. N., Fox S. A. Rapid and sensitive genotyping of hepatitis С virus by single-strand conformation polymorphism. J. Virol. Meth. 1997; 64: 11-18.
- Ильина Е. Н., Артемов Е. К., Говорун В. М. и др. Генотипирование РНК вируса гепатита С аллельспецифичной амплификацией. Кремлев. мед. Клин, вестн. 2002; 1: 38- 41.
- Abravaya К., Carrino J. J., Muldoon S., Lee H. H. Detection of point mutations with a modified ligase chain reaction (GapLCR). Nucl. Acids Res. 1995; 23: 675-682.
![](/img/style/loading.gif)